| Autor: |
Hashimoto M; Department of Thoracic Surgery, Takeda General Hospital, Kyoto, Japan., Masumoto T, Yoden M, Kaku R, Sawai S, Suzumura Y |
| Jazyk: |
japonština |
| Zdroj: |
Kyobu geka. The Japanese journal of thoracic surgery [Kyobu Geka] 2023 Dec; Vol. 76 (13), pp. 1110-1114. |
| Abstrakt: |
A man in his 50s was diagnosed with right upper lobe non-small-cell lung cancer (cT3N1M0, stage ⅢA) on bronchoscopy. The tumor was located at the right hilum and was bordered extensively on the pulmonary artery. We observed significant tumor shrinkage (ycT1bN1M0, stage ⅡB), following three cycles of systemic chemotherapy combined with an immune checkpoint inhibitor and performed right upper sleeve lobectomy + ND2a-2 via thoracotomy for radical resection. Postoperative histopathological examination showed no residual tumor cells, and the patient was deemed to have a histopathologic complete response. Currently, the patient is being followed up without adjuvant chemotherapy. Several recent studies have reported the usefulness of systemic chemotherapy combined with immune checkpoint inhibitor administration as preoperative induction chemotherapy. However, the role of adjuvant immunotherapy in patients with a histopathologic complete response remains unclear, and careful treatment decision-making is important. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
